HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Yong-Koo Park Selected Research

Proto-Oncogene Proteins c-raf

10/2012Reduced expression of Raf-1 kinase inhibitory protein in renal cell carcinoma: a significant prognostic marker.
7/2012Reduced Raf-1 kinase inhibitor protein expression predicts less favorable outcomes in patients with hepatic colorectal metastasis.
5/2012Reduced expression of Raf-1 kinase inhibitory protein predicts regional lymph node metastasis and shorter survival in esophageal squamous cell carcinoma.
1/2012Expression of Raf-1 kinase inhibitory protein in carcinoma of the ampulla of Vater.
11/2010Reduced expression of Raf-1 kinase inhibitory protein is a significant prognostic marker in patients with gallbladder carcinoma.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Yong-Koo Park Research Topics

Disease

30Neoplasms (Cancer)
11/2018 - 07/2002
20Osteosarcoma (Osteogenic Sarcoma)
12/2014 - 07/2003
16Neoplasm Metastasis (Metastasis)
04/2015 - 12/2005
11Carcinoma (Carcinomatosis)
04/2015 - 07/2002
7Ewing Sarcoma (Sarcoma, Ewing)
06/2016 - 01/2004
5Adenocarcinoma
06/2016 - 03/2009
3Renal Cell Carcinoma (Grawitz Tumor)
05/2015 - 10/2012
2Heterotopic Ossification (Ectopic Ossification)
11/2016 - 07/2016
2Lymphatic Metastasis
04/2015 - 05/2012
2Breast Neoplasms (Breast Cancer)
12/2013 - 05/2010
2Carcinogenesis
01/2013 - 05/2009
2Adenoma (Adenomas)
11/2010 - 07/2002
1Solitary Fibrous Tumors
04/2021
1Giant Cell Tumor of Bone
12/2020
1Chondrocalcinosis (Pseudogout)
07/2016
1Prostatic Neoplasms (Prostate Cancer)
06/2016
1IGA Glomerulonephritis (IGA Nephropathy)
10/2013
1Spinal Injuries (Spinal Injury)
04/2013
1Chronic Kidney Failure (Chronic Renal Failure)
08/2012
1Autosomal Dominant Polycystic Kidney (ADPKD)
08/2012
1Colorectal Neoplasms (Colorectal Cancer)
07/2012
1Esophageal Squamous Cell Carcinoma
05/2012
1Bone Resorption
06/2011
1Carcinoma in Situ
11/2010
1Cholecystitis
11/2010
1Ductal Carcinoma
05/2010
1Noninfiltrating Intraductal Carcinoma (DCIS)
05/2010
1Wounds and Injuries (Trauma)
01/2010
1Hyperplasia
08/2009
1Vascular Diseases (Vascular Disease)
08/2009
1Inflammation (Inflammations)
08/2009

Drug/Important Bio-Agent (IBA)

16Proteins (Proteins, Gene)FDA Link
06/2016 - 07/2002
11ParaffinIBA
06/2016 - 01/2004
7Formaldehyde (Formol)FDA Link
06/2016 - 01/2004
6Biological ProductsIBA
12/2014 - 09/2002
5Proto-Oncogene Proteins c-rafIBA
10/2012 - 11/2010
5Messenger RNA (mRNA)IBA
05/2008 - 12/2005
4Biomarkers (Surrogate Marker)IBA
04/2021 - 01/2008
4OsteocalcinIBA
11/2016 - 09/2002
4DNA (Deoxyribonucleic Acid)IBA
05/2015 - 03/2004
3Pemetrexed (MTA)FDA Link
12/2014 - 12/2005
3Facilitative Glucose Transport Proteins (Glucose Transporter)IBA
01/2010 - 07/2002
2OsteopontinIBA
11/2016 - 07/2016
2Growth Differentiation Factor 2IBA
07/2016 - 01/2013
2Carrier Proteins (Binding Protein)IBA
06/2016 - 01/2008
2Beclin-1IBA
04/2015 - 04/2011
2LigandsIBA
04/2014 - 06/2011
2Neoplasm Antigens (Tumor Antigens)IBA
01/2009 - 12/2005
2ezrinIBA
01/2009 - 01/2006
2Vascular Endothelial Growth Factor CIBA
04/2008 - 01/2008
2Vascular Endothelial Growth Factor Receptor-3 (Flt 4)IBA
04/2008 - 01/2008
1DenosumabFDA Link
12/2020
1CateninsIBA
07/2016
1Calcium PyrophosphateIBA
07/2016
1TensinsIBA
06/2016
1Transcriptional Regulator ERGIBA
06/2016
1AntigensIBA
06/2016
1Cysteine (L-Cysteine)FDA Link
06/2016
1Guanine NucleotidesIBA
06/2016
1Phosphoric Monoester Hydrolases (Phosphatases)IBA
06/2016
1GTP-Binding Proteins (G-Protein)IBA
06/2016
1Kazal Pancreatic Trypsin InhibitorIBA
06/2016
1Serine Proteinase Inhibitors (Serine Protease Inhibitors)IBA
06/2016
1PentosesIBA
05/2015
1Nucleic AcidsIBA
05/2015
1CCR5 Receptors (CCR5 Receptor)IBA
05/2015
1ChemokinesIBA
04/2014
1Peptides (Polypeptides)IBA
04/2014
1Coloring Agents (Dyes)IBA
04/2014
1Tumor Suppressor Protein p53IBA
12/2013
1interleukin-22 receptor (IL-22R)IBA
10/2013
1MicroRNAs (MicroRNA)IBA
08/2013
1Multidrug Resistance-Associated Protein 2IBA
01/2013
1Multidrug Resistance-Associated ProteinsIBA
01/2013
1Interleukin-8 (Interleukin 8)IBA
01/2013
1Mitogen-Activated Protein KinasesIBA
10/2012
1Fibronectins (Fibronectin)IBA
06/2012
1Syndecan-4IBA
06/2012
1Cell Adhesion MoleculesIBA
06/2012
1OsteoprotegerinIBA
06/2011
1OsteonectinIBA
02/2011
1beta CateninIBA
05/2010
1Cadherins (E-Cadherin)IBA
05/2010
1Heat-Shock Proteins (Heat-Shock Protein)IBA
01/2010
1EndostatinsIBA
10/2009
1Angiogenesis Inducing Agents (Angiogenesis Factor)IBA
10/2009
1CollagenIBA
08/2009
1CalciumIBA
08/2009
1Phosphorus (Red Phosphorus)IBA
08/2009
1Genetic Markers (Genetic Marker)IBA
05/2009
1ErbB Receptors (EGF Receptor)IBA
03/2009
1SurvivinIBA
03/2009
1Prostate-Specific Antigen (Semenogelase)IBA
01/2009

Therapy/Procedure

3Therapeutics
11/2018 - 04/2004
1Prostatectomy (Retropubic Prostatectomy)
06/2016
1Craniotomy
04/2014
1Radiotherapy
04/2013
1Renal Dialysis (Hemodialysis)
08/2012
1Nephrectomy
08/2012
1Solid-State Lasers
08/2009